Extraneal

DRUG4 trials

Sponsors

Vantive Health LLC, Ottawa Hospital Research Institute

Conditions

APDCAPDCongestive Heart FailureDiabetesESRDEnd-stage Renal Disease (ESRD)Kidney Disease

Phase 2

Heart Failure and Peritoneal Ultrafiltration

TerminatedNCT00368641

Vantive Health LLCCongestive Heart Failure

Start: 2006-08-31End: 2008-04-30Updated: 2025-07-15

Phase 3

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

CompletedNCT00567398

Vantive Health LLCDiabetes, ESRD

Start: 2008-04-30End: 2011-07-31Updated: 2025-07-22

Phase 4

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients

CompletedNCT00567489

Vantive Health LLCAPD, CAPD, Diabetes +1

Start: 2008-01-31End: 2011-07-31Updated: 2025-07-22

Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis

CompletedNCT01228279

Ottawa Hospital Research InstituteEnd-stage Renal Disease (ESRD), Kidney Disease

Start: 2007-07-31End: 2018-12-31Updated: 2021-03-15